查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1356773

血浆分馏冷链产品市场报告：2030 年趋势、预测与竞争分析

Cold Chain Products for Plasma Fractionation Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

血浆分馏冷链产品的趋势与预测

到 2030 年，全球血浆分馏冷链产品市场预计将达到 7 亿美元，2024 年至 2030 年年复合成长率为 4.6%。该市场的主要促进因素是免疫球蛋白和其他血浆产品的使用不断增加、治疗慢性疾病的血浆药物需求不断增长以及冷冻设备和系统的不断进步。全球血浆分馏冷链产品市场前景广阔，采血中心和血液成分供应商、医院和输血中心以及临床研究实验室市场存在商机。

血浆分馏冷链产品市场洞察

Lucintel 预测，温度监控设备将在预测期内达到最高成长。

由于免疫不全症病、肝病和高龄化疾病的增加，预计血液采集中心和血液成分供应商仍将是最大的细分市场。

由于对等离子冷冻库的需求不断增加以及该地区实验室先进的冷藏设备的可用性，预计北美在预测期内仍将是最大的市场。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要要素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些，由于材料或产品替代导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章血浆分馏冷链产品的全球市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业促进因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 血浆分馏冷链产品的全球市场趋势（2018-2023）与预测（2024-2030）
  • 按类型分類的血浆分馏冷链产品的全球市场
    • 超低温冷冻库
    • 血浆冷冻库
    • 温度监控装置
    • 用于血浆的接触式衝击冷冻机
    • 血液运输箱
    • 内衬冰的冰箱
    • 其他的
  • 以最终用途分類的血浆分馏冷链产品的全球市场
    • 采血中心/血液成分提供者
    • 医院/输血中心
    • CRO
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球血浆分馏冷链产品市场（按地区）
  • 北美血浆分馏冷链产品市场
  • 欧洲血浆分馏冷链产品市场
  • 亚太地区血浆分馏冷链产品市场
  • 其他地区血浆分馏冷链产品市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按类型分類的血浆分馏冷链产品的全球市场成长机会
    • 按最终用途的血浆分馏冷链产品的全球市场成长机会
    • 按地区血浆分馏冷链产品的全球市场成长机会
  • 全球血浆分馏冷链产品市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大血浆分馏冷链产品的全球市场容量
    • 全球血浆分馏冷链产品市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • B Medical systems
  • Blue Star
  • Thermo Fisher Scientific
  • Godrej and Boyce
  • Haier Biomedical
  • Eppendorf
  • Avantor
  • Biolife Solutions
简介目录

Cold Chain Products For Plasma Fractionation Trends and Forecast

The future of the global cold chain products market for plasma fractionation looks promising with opportunities in the blood collection center and blood component provider, hospital and transfusion center, and clinical research laboratorie markets. The global cold chain products market for plasma fractionation is expected to reach an estimated $700 million by 2030 with a CAGR of 4.6% from 2024 to 2030. The major drivers for this market are increasing use of immunoglobulins and other plasma products, growing need for plasma-based medicines to treat chronic conditions, and on-going advancement in refrigeration equipment and systems.

A more than 150-page report is developed to help in your business decisions.

Cold Chain Products For Plasma Fractionation by Segment

The study includes a forecast for the global cold chain products for plasma fractionation by type, end use, and region.

Cold Chain Products Market for Plasma Fractionation by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Ultra-low temperature freezer
  • Plasma freezer
  • Temperature monitoring devices
  • Plasma contact shock freezer
  • Blood transport boxes
  • Ice-lined refrigerator
  • Others

Cold Chain Products Market for Plasma Fractionation by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Blood collection centers and blood component providers
  • Hospitals and transfusion centers
  • Clinical research laboratories
  • Others

Cold Chain Products Market for Plasma Fractionation by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cold Chain Products Companies for Plasma Fractionation

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cold chain products companies for plasma fractionation cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cold chain products for plasma fractionation companies profiled in this report include-

  • B Medical Systems
  • Blue Star
  • Thermo Fisher Scientific
  • Godrej And Boyce
  • Haier Biomedical
  • Eppendorf
  • Avantor
  • Biolife Solutions

Cold Chain Products for Plasma Fractionation Market Insights

Lucintel forecasts that temperature monitoring device is expected to witness highest growth over the forecast period.

Blood collection center and blood component provider will remain the largest segment due to increasing number of diseases like hemophilia and immune deficiency disorders as well as liver diseases and rising aging population.

North America will remain the largest segment over the forecast period due to increasing demand of plasma freezer demand and availability of advanced cold storage equipment for laboratories in the region.

Features of the Global Cold Chain Products Market for Plasma Fractionation

Market Size Estimates: Cold chain products market for plasma fractionation size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cold chain products market for plasma fractionation size by type, end use, and region. in terms of value ($M).

Regional Analysis: Cold chain products market for plasma fractionation breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and region.s for the cold chain products market for plasma fractionation.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cold chain products market for plasma fractionation.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the cold chain products market for plasma fractionation size?

Answer: The global cold chain products market for plasma fractionation is expected to reach an estimated $700 million by 2030.

Q.2. What is the growth forecast for cold chain products market for plasma fractionation?

Answer: The global cold chain products market for plasma fractionation is expected to grow with a CAGR of 4.6% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the cold chain products market for plasma fractionation?

Answer: The major drivers for this market are increasing use of immunoglobulins and other plasma products, growing need for plasma-based medicines to treat chronic conditions, and on-going advancement in refrigeration equipment and systems.

Q.4. What are the major segments for cold chain products market for plasma fractionation?

Answer: The future of the global cold chain products market for plasma fractionation looks promising with opportunities in the blood collection center and blood component provider, hospital and transfusion center, and clinical research laboratorie markets.

Q.5. Who are the key cold chain products market for plasma fractionation companies?

Answer: Some of the key cold chain products for plasma fractionation companies are as follows:

  • B Medical systems
  • Blue Star
  • Thermo Fisher Scientific
  • Godrej and Boyce
  • Haier Biomedical
  • Eppendorf
  • Avantor
  • Biolife Solutions

Q.6. Which cold chain products market for plasma fractionation segment will be the largest in future?

Answer: Lucintel forecasts that temperature monitoring device is expected to witness highest growth over the forecast period.

Q.7. In cold chain products market for plasma fractionation, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to increasing demand of plasma freezer demand and availability of advanced cold storage equipment for laboratories in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cold chain products market for plasma fractionation by type (ultra-low temperature freezer, plasma freezer, temperature monitoring devices,plasma contact shock freezer, blood transport boxes, ice-lined refrigerator, and others), end use (blood collection centers and blood component providers, hospitals and transfusion centers, clinical research laboratories, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cold Chain Products Market for Plasma Fractionation: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Cold Chain Products Market for Plasma Fractionation Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Cold Chain Products Market for Plasma Fractionation by Type
    • 3.3.1: Ultra-low Temperature Freezer
    • 3.3.2: Plasma Freezer
    • 3.3.3: Temperature Monitoring Devices
    • 3.3.4: Plasma Contact Shock Freezer
    • 3.3.5: Blood Transport Boxes
    • 3.3.6: Ice-lined Refrigerator
    • 3.3.7: Others
  • 3.4: Global Cold Chain Products Market for Plasma Fractionation by End Use
    • 3.4.1: Blood collection Centers and Blood Component Providers
    • 3.4.2: Hospitals and Transfusion Centers
    • 3.4.3: Clinical Research Laboratories
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Cold Chain Products Market for Plasma Fractionation by Region
  • 4.2: North American Cold Chain Products Market for Plasma Fractionation
    • 4.2.2: North American Cold Chain Products Market for Plasma Fractionation by End Use: Blood collection Centers and Blood Component Providers, Hospitals and Transfusion Centers, Clinical Research Laboratories, and Others
  • 4.3: European Cold Chain Products Market for Plasma Fractionation
    • 4.3.1: European Cold Chain Products Market for Plasma Fractionation by Type: Ultra-low temperature Freezer, Plasma Freezer, Temperature Monitoring Devices, Plasma Contact Shock Freezer, Blood Transport Boxes, Ice-lined Refrigerator, and Others
    • 4.3.2: European Cold Chain Products Market for Plasma Fractionation by End Use: Blood collection Centers and Blood Component Providers, Hospitals and Transfusion Centers, Clinical Research Laboratories, and Others
  • 4.4: APAC Cold Chain Products Market for Plasma Fractionation
    • 4.4.1: APAC Cold Chain Products Market for Plasma Fractionation by Type: Ultra-low temperature Freezer, Plasma Freezer, Temperature Monitoring Devices, Plasma Contact Shock Freezer, Blood Transport Boxes, Ice-lined Refrigerator, and Others
    • 4.4.2: APAC Cold Chain Products Market for Plasma Fractionation by End Use: Blood collection Centers and Blood Component Providers, Hospitals and Transfusion Centers, Clinical Research Laboratories, and Others
  • 4.5: ROW Cold Chain Products Market for Plasma Fractionation
    • 4.5.1: ROW Cold Chain Products Market for Plasma Fractionation by Type: Ultra-low temperature Freezer, Plasma Freezer, Temperature Monitoring Devices, Plasma Contact Shock Freezer, Blood Transport Boxes, Ice-lined Refrigerator, and Others
    • 4.5.2: ROW Cold Chain Products Market for Plasma Fractionation by End Use: Blood collection Centers and Blood Component Providers, Hospitals and Transfusion Centers, Clinical Research Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cold Chain Products Market for Plasma Fractionation by Type
    • 6.1.2: Growth Opportunities for the Global Cold Chain Products Market for Plasma Fractionation by End Use
    • 6.1.3: Growth Opportunities for the Global Cold Chain Products Market for Plasma Fractionation by Region
  • 6.2: Emerging Trends in the Global Cold Chain Products Market for Plasma Fractionation
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cold Chain Products Market for Plasma Fractionation
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cold Chain Products Market for Plasma Fractionation
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: B Medical systems
  • 7.2: Blue Star
  • 7.3: Thermo Fisher Scientific
  • 7.4: Godrej and Boyce
  • 7.5: Haier Biomedical
  • 7.6: Eppendorf
  • 7.7: Avantor
  • 7.8: Biolife Solutions